Jörg Mahlich graduated in economics from the University of Kiel/Germany and holds a doctoral degree in economics from the University of Vienna/Austria. He is currently heading the health economics department at Janssen Japan in Tokyo. Previous to that he was in the market access team of Janssen (Germany) where he was involved in several German HTA submissions. He is a research affiliate at the Düsseldorf Institute for Competition Economics (DICE) of the University of Düsseldorf/Germany. Until his move to Japan, he was also teaching Economics and Health Economics at the Economics Department of the University of Vienna. He is interested in pharmaceutical economics and policy including HTA.